Previous 10 | Next 10 |
home / stock / numi:cc / numi:cc news
Numinus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSD Canada NewsWire VANCOUVER, BC , Dec. 13, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company adva...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results Canada NewsWire Q4 Fiscal 2023 Highlights Q4 2023 revenues grew 46.8% year-over-year to $6.1 million Q4 2023 revenues grew 1.7% from the previous quarter Gross profit of $1.8...
Numinus to Host Q4 2023 and Annual Results Conference Call on November 29, 2023 Canada NewsWire VANCOUVER, BC , Nov. 21, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing i...
Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research Canada NewsWire VANCOUVER, BC , Oct. 3, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: ...
Numinus Wellness Inc. Announces At-The-Market Offering Equity Program Canada NewsWire VANCOUVER, BC , Sept. 25, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), is pleased to announce that it has established an at-the-ma...
Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine Canada NewsWire Study Results are widely regarded as the final step before MDMA-assisted therapy is reviewed by the FDA for wider patient access. Numinus continues to support grea...
Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations Canada NewsWire The Company is ceasing operating activities at Numinus Bioscience – its non-revenue producing research lab, and is consolidating clinic ...
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023 Canada NewsWire VANCOUVER, BC , Aug. 9, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) – a mental health care ...
2023-07-26 08:45:24 ET Palm Beach, FL – July 26, 2023 – FinancialNewsMedia.com News Commentary – Psychedelic and hallucinogenic medicines market have been growing consistently over the past several years and are expected to continue to rise in the coming yea...
Numinus Wellness Inc. Reports Q3 2023 Results Canada NewsWire Q3 2023 revenues grew 713.3% year-over-year to $6.0 million Q3 2023 revenues grew 12.6% from previous quarter Gross profit of $2.1 million , increased 1051.6% year-over-year Staff r...
News, Short Squeeze, Breakout and More Instantly...
Numinus Wellness Inc. Company Name:
NUMI:CC Stock Symbol:
TSXC Market:
Numinus Wellness Inc. Website:
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results Canada NewsWire Q3 Fiscal 2024 Highlights Revenue of $4.3 million , a 1.9% decline over Q2 2024 Gross profit of $1.0 million , a 9.8% decline over Q2 2024 Cash position of $3.7 million ...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 Canada NewsWire VANCOUVER, BC , July 10, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing tradition...
Numinus Wellness Announces Resignation of Director Canada NewsWire VANCOUVER, BC , June 24, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional a...